Conflicts of Interest
L.B. reports serving as a Scientific Advisory Board member for Sanofi, Ionnis, Pfizer and NovoNordisk; being the recipient of a research grant from AstraZeneca; having received speaker fees from Sanofi and Bayer and having founded the Spin-offs Glycardial Diagnostics SL and Ivastatin Therapeutics S (all unrelated to this work). T.P. reports being cofounder of the Spin-offs Glycardial Diagnostics SL and Ivastatin Therapeutics S (all unrelated to this work). No further declarations are made by the remaining authors.